Stephen Gately

Stephen Gately serves as Chief Executive Officer at Translational Drug Development (TD2). Translational Drug Development (TD2) operates in the research sector with approximately 150.0 employees. The company is headquartered in Scottsdale, Arizona. Translational Drug Development (TD2) generates annual revenue of 15000000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Translational Drug Development (TD2).
• • 1,458 executive contacts are available in Arizona.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 WP Engine Hubspot Google Tag Manager Facebook Widget Linkedin Widget Linkedin Login Shutterstock Google Font API Hotjar Jobscore DoubleClick Conversion Facebook Login (Connect) Linkedin Marketing Solutions DoubleClick Bootstrap Framework Google Dynamic Remarketing Google AdSense WordPress.org Mobile Friendly Remote

xenograft models bioanalytical services primary gbm panel ariiel radiation lab oncology clinical trial management ind filings regulatory affairs fda interactions data management preclinical oncology translational drug development flow cytometry adc drug development radiopharmaceutical drug development syngeneic studies immunooncology pdx models humanized pdx research services clinical trial services study design protocol development patient identification site management regulatory support biostatistics pharmacovigilance medical monitoring etmf management quality assurance therapeutic areas radiolabeled pharmaceuticals hematologic malignancies full program management consulting protocol design program budget executive plan trial enablement regulatory writing submission filing gap analysis model systems syngeneic tumor models orthotopic tumor models patient derived xenograft humanized mouse models diet-induced obesity models adoptive cell therapy models dmpk/adme services in vivo characterization in vitro characterization optical imaging therapeutic evaluation antibody drug conjugates clinical study management pk/adme innovative cancer therapies precision oncology oncology cro clinical trial metrics data quality assurance adverse event reconciliation system validation cdisc compliance oncology drug development contract research organization clinical trial management preclinical services advanced flow cytometry targeted therapies immuno-oncology antibody-drug conjugates radiopharmaceuticals precision medicine clinical trial execution biomarker discovery translational research community oncology practices patient access drug development ecosystem strategic collaboration scientific innovation patient outcomes clinical trial sites biopharmaceutical companies oncology research operational excellence global clinical trials patient-derived xenografts pharmacokinetics safety profiling fda compliance oncology therapies cancer treatment acceleration

TF

Tara Franks Chief Operating Officer at Translational Drug Development (TD2)

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Stephen Gately in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Translational Drug Development (TD2).

Stephen Gately's Position in the MessageCEO Database

• •Stephen Gately is 1 of 2 verified executive contacts we track at Translational Drug Development (TD2).
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •1,384 verified executive contacts in Arizona are in the database.
• •41 verified contacts work at research companies in the 150.0 employee range (same size as Translational Drug Development (TD2)).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Stephen Gately directly?

Stephen Gately's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Translational Drug Development (TD2). Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Stephen Gately work for?

Stephen Gately is Chief Executive Officer at Translational Drug Development (TD2), a company in the research sector with 150.0 employees. The company is based in Scottsdale, Arizona.

Can I pitch or sell to Stephen Gately?

As Chief Executive Officer at Translational Drug Development (TD2), Stephen Gately is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Stephen Gately directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Stephen Gately in?

Stephen Gately works in the research industry as Chief Executive Officer at Translational Drug Development (TD2). MessageCEO provides verified contact information for executives across all major industries.

Is Stephen Gately's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Stephen Gately's profile is kept up-to-date with the latest available information.

Last updated: June 23, 2026